)
)
Wayne Doyle
Associate Director, Head of Scientific Strategy,
EclipseBio
Dr. Wayne Doyle earned his Ph.D. at UT Southwestern, advanced the BRAIN Initiative at UC San Diego as a postdoctoral fellow mapping human brain cell types.
He later joined Active Motif, where he led the bioinformatics team, developing analytical pipelines and supporting partners’ research and drug development programs. In 2022, Dr. Doyle moved to Eclipsebio, where he now directs strategy for their integrative partnership platforms to support RNA therapeutic development, including end-to-end drug characterization and AI-powered optimization solutions.
Sessions
-
Better Inputs, Better Outputs: High-Dimensional Data for Tomorrow’s RNA Medicines28-Jan-2026AI In Drug Discovery Stage